Quantum Genesis AI Corp. (OTC: QGAI) announced today that OTC Markets Group has removed the Caveat Emptor designation previously applied to the Company's securities. The designation, which warns investors to exercise caution, was lifted following a cooperative review process in which Quantum Genesis AI provided information and responded to inquiries.
"We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation," said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. "Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement. We thank OTC Markets for their professionalism and assistance, and we remain committed to maintaining open communication with our shareholders and the marketplace."
The removal of the Caveat Emptor label is significant for the Company and its shareholders. Caveat Emptor is a designation applied by OTC Markets to companies that may have raised concerns regarding public interest, such as insufficient current information, promotional activity, or other regulatory issues. Its removal indicates that the Company has addressed those concerns, which could lead to increased trading liquidity and investor confidence. For OTC-listed companies, shedding the Caveat Emptor designation is often a critical step toward regaining full market access and credibility.
Quantum Genesis AI focuses on advancing next-generation technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. The Company's strategy includes leveraging data-driven tools to support research and development across emerging sectors. With the Caveat Emptor designation removed, the Company is now better positioned to pursue its strategic initiatives and communicate its progress to investors without the overhang of the warning label.
The Company continues to advance its initiatives in AI and computational modeling while maintaining a commitment to responsible corporate governance and public company compliance. Quantum Genesis AI intends to provide timely updates through its public disclosures and shareholder communications. More information is available at www.qgaicorp.com and the Company's profile at www.otcmarkets.com/stock/QGAI.
The removal of the Caveat Emptor designation marks a positive development for Quantum Genesis AI, potentially restoring investor confidence and enabling the Company to focus on its growth and innovation goals without the stigma of the cautionary label. Shareholders and market participants will be watching for further updates on the Company's business activities and corporate developments.
